Fc receptor-like 3 - 169 C/T polymorphism and RA susceptibility: A meta-analysis

Rheumatology International

Volumn 30, Issue 7, 2010, Pages 947-953

  Lee, Young Ho ^a   Woo, Jin Hyun ^a   Choi, Seong Jae ^a   Ji, Jong Dae ^a   Song, Gwan Gyu ^a  

^a Korea University College of Medicine   (South Korea)

Author keywords

FCRL3; Meta analysis; Polymorphisms; Rheumatoid arthritis

Indexed keywords

FC RECEPTOR; FC RECEPTOR LIKE 3; UNCLASSIFIED DRUG;

ARTICLE; DNA POLYMORPHISM; ETHNICITY; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; PRIORITY JOURNAL; RECEPTOR GENE; RHEUMATOID ARTHRITIS; RISK FACTOR; STATISTICAL SIGNIFICANCE; SYSTEMIC LUPUS ERYTHEMATOSUS;

ARTHRITIS, RHEUMATOID; ASIAN CONTINENTAL ANCESTRY GROUP; BASE SEQUENCE; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENE FREQUENCY; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INHERITANCE PATTERNS; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, IMMUNOLOGIC;

EID: 77955097204     PISSN: 01728172     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00296-009-1082-5     Document Type: Article

References (24)

1. Harris ED Jr (1990) Rheumatoid arthritis. Pathophysiology and implications for therapy. N Engl J Med 322:1277-1289.
2. Wordsworth P, Bell J (1991) Polygenic susceptibility in rheumatoid arthritis. Ann Rheum Dis 50:343-346. doi:10.1136/ard.50.6.343.
3. Harley JB, Kelly JA, Kaufman KM (2006) Unraveling the genetics of systemic lupus erythematosus. Springer Semin Immunopathol 28:119-130. doi:10.1007/s00281-006-0040-5. (Pubitemid 44526313)
4. Kochi Y, Yamada R, Suzuki A, Harley JB, Shirasawa S, Sawada T, Bae SC, Tokuhiro S, Chang X, Sekine A, Takahashi A, Tsunoda T, Ohnishi Y, Kaufman KM, Kang CP, Kang C, Otsubo S, Yumura W, Mimori A, Koike T, Nakamura Y, Sasazuki T, Yamamoto K (2005) A functional variant in FCRL3, encoding Fc receptor-like 3, is associated with rheumatoid arthritis and several autoimmunities. Nat Genet 37:478-485. doi:10.1038/ng1540. (Pubitemid 40617275)
5. Tamiya G, Shinya M, Imanishi T, Ikuta T, Makino S, Okamoto K, Furugaki K, Matsumoto T, Mano S, Ando S, Nozaki Y, Yukawa W, Nakashige R, Yamaguchi D, Ishibashi H, Yonekura M, Nakami Y, Takayama S, Endo T, Saruwatari T, Yagura M, Yoshikawa Y, Fujimoto K, Oka A, Chiku S, Linsen SE, Giphart MJ, Kulski JK, Fukazawa T, Hashimoto H, Kimura M, Hoshina Y, Suzuki Y, Hotta T, Mochida J, Minezaki T, Komai K, Shiozawa S, Taniguchi A, Yamanaka H, Kamatani N, Gojobori T, Bahram S, Inoko H (2005) Whole-genome association study of rheumatoid arthritis using 27 039 microsatellites. Hum Mol Genet 14:2305-2321. doi:10.1093/hmg/ddi234. (Pubitemid 41417994)
6. Kyogoku C, Dijstelbloem HM, Tsuchiya N, Hatta Y, Kato H, Yamaguchi A, Fukazawa T, Jansen MD, Hashimoto H, van de Winkel JG, Kallenberg CG, Tokunaga K (2002) Fcgamma receptor gene polymorphisms in Japanese patients with systemic lupus erythematosus: contribution of FCGR2B to genetic susceptibility. Arthritis Rheum 46:1242-1254. doi:10.1002/art.10257. (Pubitemid 34525832)
7. Davis RS, Dennis G Jr, Odom MR, Gibson AW, Kimberly RP, Burrows PD, Cooper MD (2002) Fc receptor homologs: newest members of a remarkably diverse Fc receptor gene family. Immunol Rev 190:123-136. doi:10.1034/j.1600-065X.2002. 19009.x. (Pubitemid 36071930)
8. Ikari K, Momohara S, Nakamura T, Hara M, Yamanaka H, Tomatsu T, Kamatani N (2006) Supportive evidence for a genetic association of the FCRL3 promoter polymorphism with rheumatoid arthritis. Ann Rheum Dis 65:671-673. doi:10.1136/ard.2005. 043489.
9. Choi CB, Kang CP, Seong SS, Bae SC, Kang C (2006) The - 169C/T polymorphism in FCRL3 is not associated with susceptibility to rheumatoid arthritis or systemic lupus erythematosus in a case-control study of Koreans. Arthritis Rheum 54:3838-3841. doi:10.1002/art.22248. (Pubitemid 44955885)
10. Owen CJ, Kelly H, Eden JA, Merriman ME, Pearce SH, Merriman TR (2007) Analysis of the Fc receptor-like-3 (FCRL3) locus in Caucasians with autoimmune disorders suggests a complex pattern of disease association. J Clin Endocrinol Metab 92:1106-1111. doi:10.1210/jc.2006-2183. (Pubitemid 46465689)
11. Eyre S, Bowes J, Potter C, Worthington J, Barton A (2006) Association of the FCRL3 gene with rheumatoid arthritis: a further example of population specificity? Arthritis Res Ther 8:R117. doi:10.1186/ar2006.
12. Sanchez E, Callejas JL, Sabio JM, de Haro M, Camps M, de Ramon E, Garcia-Hernandez FJ, Koeleman B, Martin J, Gonzalez-Escribano MF (2006) Polymorphisms of the FCRL3 gene in a Spanish population of systemic lupus erythematosus patients. Rheumatology (Oxford) 45:1044-1046. doi:10.1093/ rheumatology/kel160. (Pubitemid 44283066)
13. Hu X, Chang M, Saiki RK, Cargill MA, Begovich AB, Ardlie KG, Criswell LA, Seldin MF, Amos CI, Gregersen PK, Kastner DL, Remmers EF (2006) The functional ¡169T!C single-nucleotide polymorphism in FCRL3 is not associated with rheumatoid arthritis in white North Americans. Arthritis Rheum 54:1022-1025. doi:10.1002/art.21636.
14. Martinez A, Sanchez E, Valdivia A, Orozco G, Lopez-Nevot MA, Pascual-Salcedo D, Balsa A, Fernandez-Gutierrez B, de la Concha EG, Garcia-Sanchez A, Koeleman BP, Urcelay E, Martin J (2006) Epistatic interaction between FCRL3 and NFkappaB1 genes in Spanish patients with rheumatoid arthritis. Ann Rheum Dis 65:1188-1191. doi:10.1136/ard.2005.048454. (Pubitemid 44277394)
15. Newman WG, Zhang Q, Liu X, Walker E, Ternan H, Owen J, Johnson B, Greer W, Mosher DP, Maksymowych WP, Bykerk VP, Keystone EC, Amos CI, Siminovitch KA (2006) Rheumatoid arthritis association with the FCRL3 - 169C polymorphism is restricted to PTPN22 1858T-homozygous individuals in a Canadian population. Arthritis Rheum 54:3820-3827. doi:10.1002/art.22270. (Pubitemid 44955883)
16. Thabet MM, Wesoly J, Slagboom PE, Toes RE, Huizinga TW (2007) FCRL3 promoter 169 CC homozygosity is associated with susceptibility to rheumatoid arthritis in Dutch Caucasians. Ann Rheum Dis 66:803-806. doi:10.1136/ard.2006. 064949. (Pubitemid 46846701)
17. Egger M, Smith GD, Phillips AN (1997) Meta-analysis: principles and procedures. BMJ 315:1533-1537.
18. Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315:629-634.
19. Higgins JP, Thompson SG (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21:1539-1558. doi:10.1002/sim.1186. (Pubitemid 34746062)
20. Yusuf S, Peto R, Lewis J, Collins R, Sleight P (1985) Beta blockade during and after myocardial infarction: an overview of the randomized trials. Prog Cardiovasc Dis 27:335-371. doi:10.1016/S0033-0620(85)80003-7. (Pubitemid 15107153)
21. Lee YH, Rho YH, Choi SJ, Ji JD, Song GG (2007) PADI4 polymorphisms and rheumatoid arthritis susceptibility: a meta-analysis. Rheumatol Int 27:827-833. doi:10.1007/s00296-007-0320-y. (Pubitemid 46906647)
22. Lee YH, Rho YH, Choi SJ, Ji JD, Song GG, Nath SK, Harley JB (2007) The PTPN22 C1858T functional polymorphism and autoimmune diseases: a meta-analysis. Rheumatology (Oxford) 46:49-56. doi:10.1093/rheumatology/kel170. (Pubitemid 44932783)
23. Choi SJ, Rho YH, Ji JD, Song GG, Lee YH (2006) Genome scan meta-analysis of rheumatoid arthritis. Rheumatology (Oxford) 45:166-170. doi:10.1093/ rheumatology/kei128. (Pubitemid 43160077)
24. Begovich AB, Chang M, Schrodi SJ (2007) Meta-analysis evidence of a differential risk of the FCRL3 - 169T→C polymorphism in white and East Asian rheumatoid arthritis patients. Arthritis Rheum 56:3168-3171. doi:10.1002/art.22857. (Pubitemid 47502766)